Medtronic. Dexcom. Abbott. Sanofi. Google. A lot of very large, well-known companies are investing heavily into innovating the diabetes space, and that innovation is exciting. But a disproportionate ...

Study design. This prospective, randomized, controlled, parallel-group study compared the use of pen devices with conventional vials and syringes for the administration of insulin in hospitalized ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. What part of the phrase ‘risk of spreading blood-borne disease’ did the ...

(Reuters Health) - A warning for people who use insulin pens: Not shaking your NPH insulin pen before injecting can result in wide variations in your insulin level and blood sugar control, researchers ...

Incorporating insulin into your daily life can take some getting used to. From packing your on-the-go bag to prepping your syringe or insulin pen, here are tips to get you started. Insulin may be one ...

MADRID — Day of the week, age, snacking, and being more engaged with smart insulin pens are important factors that affect adherence to injecting bolus insulin in people living with diabetes (PLWD), ...

A CMS letter to its state survey agency directors reiterates that insulin pens should only be used on a single patient. According to the letter, CMS has received reports that some providers may be ...

Nicole Smith-Holt’s son, Alec, died in 2017 from diabetic ketoacidosis, a condition that occurs when the body doesn’t have enough insulin. Alec had Type 1 diabetes. The 26-year-old had been recently ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted 501(k) clearance to a smart cap sensor for disposable insulin pens, according to an industry ...

Ahead of World Diabetes Day, Doctors Without Borders/Médecins Sans Frontières (MSF) called for all insulin manufacturers to provide injection pen devices at $1 per pen. The humanitarian organization ...

Griffin Hospital in Derby, Conn., has settled a class action lawsuit nine years after they warned patients they could have a blood-borne disease as a result of hospital employees who reused insulin ...

Sanofi is cutting the list price of Lantus, its most widely prescribed insulin in the US, by 78% and establishing a $35 monthly cap for those with private insurance, the company announced Thursday.